Xtx Topco LTD Cyclerion Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.56 - $2.99 $16,197 - $31,045	-10,383 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.73 - $4.13 $20,707 - $31,326	-7,585 Reduced 42.21%	10,383 $32,000
Q2 2021 Aug 12, 2021	BUY	$2.18 - $4.29 $10,034 - $19,746	4,603 Added 34.44%	17,968 $70,000
Q1 2021 May 14, 2021	BUY	$2.69 - $5.12 $35,951 - $68,428	13,365 New	13,365 $37,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $100M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.